Treatment	Cause	Edge Weight	Shared Publications
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 38: Liver Damage, Inflammation, and Fibrogenesis as Systemic Consequences in COPD Pathogenesis	0.6666666666666666	238
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 19: Adipose Tissue Inflammation and Metabolic Dysfunction in the Pathogenesis of COPD	0.19480519480519481	60
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 23: Hormetic Regulation of Oxidative Stress and Inflammatory Pathways in COPD and Related Ischemic Diseases	0.053208137715179966	34
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 8: Estrogen-Regulated Autophagy and miRNA Networks in Endometriosis-Related COPD Pathogenesis	0.04046242774566474	21
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 33: Gut Microbiota Dysbiosis and Intestinal Immune Homeostasis Disruption in COPD Pathogenesis	0.024630541871921183	10
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 13: Hyperglycemia-Induced Oxidative Stress and Inflammation in Diabetic COPD Comorbidity	0.022641509433962263	6
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 4: NLRP3 Inflammasome-Mediated Inflammatory Dysregulation in COPD Pathogenesis and Therapeutic Targets	0.016129032258064516	3
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 37: Acute Lung Injury and Inflammatory Dysregulation as Precursors to COPD Progression and Exacerbation	0.015345268542199489	6
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 16: Unveiling Novel Targets and Immune Mechanisms in COPD Pathogenesis: From Muscle Metabolism to Macrophage Polarization	0.014265335235378032	10
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 18: Unraveling the Molecular Interplay of Î² Adrenoceptors, Gasotransmitters, and Sulfonation in COPD Pathogenesis	0.013916500994035786	7
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 26: Epigenetic and Inflammatory Regulation of Oxidative Stress and Nitric Oxide Production in COPD Pathogenesis	0.013761467889908258	9
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 10: Natural Bioactive Polyphenols and Flavonoids as Potential Therapeutic Agents in COPD Prevention	0.012552301255230125	6
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 17: Eicosanoid Dysregulation and Cox Inhibition: Unveiling the Complex Links between COPD and Cardiovascular, Gastrointestinal, and Metabolic Disorders	0.009202453987730062	3
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 20: Lipid Dysregulation and Inflammation in Atherosclerosis-Related COPD Etiology and Progression	0.008645533141210375	3
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 35: Cardiovascular and Metabolic Comorbidities as Modifiable Risk Factors for COPD Exacerbation	0.00646551724137931	3
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 5: Environmental Toxicants and Cyclooxygenase Inhibition in Gastrointestinal COPD Pathways	0.006230529595015576	2
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 39: Renal Dysfunction and Inflammation as Critical Modulators of COPD Pathogenesis and Exacerbation Risk	0.006230529595015576	2
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 6: Intrauterine and Chronic Inflammation-Driven Dysregulation of Anti-Inflammatory Responses in COPD Development	0.004201680672268907	2
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 28: Inflammatory Pathways Linking Osteoarthritis and COPD: Shared Mechanisms of Cartilage Destruction and Matrix Degradation	0.0038910505836575876	1
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 25: Wound Healing Dysregulation and Tissue Remodeling as Systemic Influencers of COPD Pathogenesis	0.003472222222222222	1
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 1: TNF Inhibition and Modulation of COPD Inflammatory Profiles in Complex Comorbidities	0.0033444816053511705	1
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 31: Cardiac Dysfunction and Inflammation: A Novel Link to COPD Pathogenesis and Comorbidity	0.002793296089385475	1
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 7: Congenital and Interstitial Lung Diseases as Modifiers of Emphysema and Fibrosis in COPD	0.001996007984031936	1
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 36: Elucidating the Complex Genetic and Epithelial Mechanisms Underlying COPD Susceptibility and Progression	0.0019550342130987292	2
COPD Treatment Cluster 20: Hepatoprotective Strategies and Immunomodulatory Therapies for Inflammatory Liver Damage and COPD	COPD Cause Cluster 32: Autoimmune and Autoinflammatory Conditions as Indicators of COPD Risk and Disease Progression	0.0015015015015015015	1
